|
Looking Forward
The future of Medicare and health service financing
Stephen R Leeder and Ian A McAuley
MJA 2000; 173: 48-51
If we can afford to pay for healthcare, we can afford Medicare
Make a
comment -
Register to be notified of new articles by e-mail -
Current contents list -
More articles on Administration and health services
|
"Never make predictions, particularly about the future", was George
Bernard Shaw's advice to futurologists. Shaw saw more of the future
than most -- he died in 1950, aged 94, when the life expectancy of men in
Britain was 67 years. Two years earlier, Aneurin Bevan,* Minister for
Health in the Attlee Government, had introduced the National Health Service
(NHS) Act, the prototype for universal tax-funded healthcare like
Australia's Medibank and Medicare.
When the NHS was introduced, the prevailing view was that healthcare
expenditure would stabilise once unmet need had been satisfied. But,
from 1900 to 1950, the life expectancy of men in Britain had risen from
49 to 67 years, because of improved living standards and, latterly,
cures for infections.1 Prescient indeed would have
been the academic in 1950 who could have foreseen that lengthened life
would result in a host of new healthcare needs, that technologies
would be developed to meet those needs, and that Bevan's stability of
expenditure on health would prove to be illusory.
Speculating on the future of healthcare delivery is no less hazardous
now than it was in 1948. Nevertheless, the major forces shaping the
future generally are manifest in present trends. If we were
developing scenarios about commodity prices we might well accept
that, in a globalised world economy, the policies of national
governments have, at most, a marginal effect. In the case of
healthcare, however, this is no easy task.
The experience of the past 25 years suggests we might expect at least
four changes of government over the next 25 years. That would indicate
an on/off sequence for Medicare, much as we have seen in the past 25
years, and this has not been totally related to which side of politics
is in power. During Labor's time in office, the governments of Bob
Hawke and Paul Keating reintroduced universal hospital care, but
also brought in a much higher level of patient copayments in
healthcare, particularly for pharmaceuticals. The present
Liberal-National Coalition Government has reasserted a commitment
to Medicare, and has tended to shy away from market forces in the
private sector, encouraging community-rated insurance rather than
self-reliance.2 Yet, at the same time, the
present government suggests strongly that those who can afford to
have private insurance should do so. A similar sentiment was
evident in the proposals of the Labor Health Minister, Graham
Richardson, in 1993.
The vision of Medibank, and of Medicare, as defined by Neal Blewett
when Minister for Health in the Hawke Government, was as a universal shared system. During the
1990s, however, there was political pressure within both parties to
redefine Medicare, in particular as regards access to public
hospitals, as a charity system for the old and indigent. Because the
basic principles of Medicare are not regularly articulated,
Medicare becomes pliable to the fashions of government policy and
subject to expedient interventions to solve real or perceived
problems.
Forty years ago, Charles Lindblom coined the term "muddling through"
to describe a policy-making process which has no clear end or
objective, but which lurches, reacting to one crisis after
another.3 The Productivity
Commission's modest proposal -- that the Commonwealth Government
hold a broad public inquiry into Australia's healthcare system --
which might have led to a less muddled health policy, met with
rejection.4
As an alternative to muddling, we can take account of probable changes
in demand (especially ageing) and supply (especially technology) of
healthcare and build a policy for the future.
|
Demand -- an ageing population | |
Box 1 shows population projections to 2025 for the 80 years and over age
group. This age group will almost double in size over the next 25 years.
Simple extrapolations of expenditure based on these projections are
alarmist, for several reasons. For a start, many countries are
already coping successfully with older populations (Box 2). The
Scandinavian countries, especially, already have a population
structure similar to that predicted for Australia in 2025, and are
delivering healthcare for less than 10% of gross domestic product
(GDP). These countries demonstrate the capacity of a single,
national insurance scheme (similar to Medicare) to keep costs under
control while providing quality care to an aged population.
A further factor that may diminish demand for care among older people
may be changes in lifestyle -- smoking, diet, and exercise are all
major determinants of healthcare needs. Dr Wendy Everett, Director
of the Robert Wood Johnson Foundation's health programs, suggests
(as have many others) that behaviour contributes to 50% of our health
status.7 These effects take decades
to manifest. Thus, it is the "baby boomers", who grew up in the Golden
Age of postwar prosperity and equality, whose lifestyle choices will
become apparent when they are around the age of 70 to 80 in the year 2025.
Another determinant is consumer attitudes to healthcare. Daniel
Callahan, in his book False hopes, predicts the implosion of
healthcare under the weight of grasping demand for perfect health
unless all of us (in the case of the United States, especially older
people) modulate our demands.8 He fears that the commercial
imperatives that drive new pharmaceutical, biotechnological and
bioengineering industries will further push demand for tinkering
and spare parts to completely unsustainable levels. As an
alternative, he posits education of the public that they cannot have
it all, and this must begin now if a shred of equity in how healthcare is
provided is to be retained.
Thus, while the arithmetic of ageing is not complex, much depends on
background economic capacity and the sociology of demand of the
country concerned. Unless demand is disciplined, it is easy to see
market forces overwhelming healthcare budgets. In that case, a
scramble for care will occur, with only the rich doing well, further
widening the already depressing gradients in health and healthcare
between the rich and the poor.9,10 Presuming instead a more
civilised society with a central health insurance agency such as
Medicare, the omens are by no means bleak, as our Scandinavian
colleagues demonstrate.
|
Supply -- the role of technology | |
Technological growth is blamed for much of the increase in health
costs. Dr Joseph Newhouse, of Harvard University, told a National
Health Summit in Sydney in 1991 that he attributed the increase in
healthcare expenditure in the United States principally to
technological change.11 He referred to the "march
of science and the increased capabilities of medicine" as a large part
of the cause, and cited renal (kidney) dialysis, transplantation,
artificial joints and monoclonal antibodies (and other products of
genetic engineering) as examples of this.
However, the role of new technology is a mixed one, and, while there may
be a Galbraithian "technological imperative", to suppose that it
cannot be modified with time according to human design seems a
defeatist position. Many technologies have revolutionised patient
comfort, especially the replacement of old diagnostic procedures
with new, far less invasive ones. The same can be said for many
therapies that have enabled the massive movement away from prolonged
inpatient care to ambulatory service. A step in the direction of the
sane use of new technology is the development, in 1998, of processes of
critical appraisal for services that might be supplied by Medicare.
We have not yet seen what clinical care based on insights into the human
genome may achieve, but not to consider this as a significant aspect of
demand for future healthcare would be foolish.
The other aspect of technology likely to have a profound effect is the
Internet. It is shifting the locus of information in
healthcare.12 Will it result in more
shopping around, more time spent in argument, or will it result in more
self-help displacing the need for formal care? Will it result in more
mishaps through partial knowledge? How will it relate to Medicare?
|
Can we afford Medicare? | |
If we can afford to pay for healthcare, we can afford Medicare. That may
sound glib, but, if we choose to share all or some of our healthcare
costs, then Medicare is both the fairest and most efficient means of
sharing.
Community-rated private health insurance (a "privatised" tax) is a
clumsy way to do what the taxation system does well. There is nothing
that community-rated private health insurance does that Medicare
and the taxation system cannot do better. The administrative
expenses of private health insurance are $0.6 billion per annum, or
12.4% of premiums, compared with 3.7% for the Health Insurance
Commission.13,14 The taxation system
achieves community rating without the need for complex arrangements
(such as apply with private health insurance), with "lifetime cover"
and reinsurance, and because taxation is progressive it is fairer
than private insurance.
What would be the financial consequences of doing away with private
insurance? Health insurance funds pay out $3.1 billion a year in
hospital benefits.13 Of that, 30% is subsidised
by the Commonwealth Government. Therefore, $2.2 billion of
additional public funding could substitute for this funding. That
could be met with a 0.75% increase in the Medicare levy. Its immediate
effect would be to eliminate a large private bureaucracy. Its longer
term effect would be to bring to the healthcare market the discipline
of a single national insurer. Box 3 shows that countries with a larger
proportion of healthcare funding passing through the public sector,
through universal national health schemes like Medicare and
Britain's NHS, tend to have much lower total healthcare costs.
Would eliminating private insurance represent "socialised
medicine"? No. It is quite possible to fund a private hospital system
without private insurance. Medicare funds can just as easily go to
private hospitals as to public hospitals.
Would it be possible politically to raise taxes to pay for a universal
Medicare? The evidence seems strongly to suggest it would. In both the
1993 and 1996 elections, healthcare was a major issue among voters. In
1993, the Coalition had promised private health insurance
initiatives, while Labor did not, being more committed to Medicare.
Polling researchers asked people which party was closest to their own
views on various issues, including health policy. In response to that
question, Labor had a 19% lead over the Coalition. In 1996 both parties
promised support for private health insurance and the same polling
found Labor's lead on healthcare had fallen to 5%.15 This year, in a
multination poll, a small majority of Australians said they were in
favour of higher taxes and higher public spending, with healthcare,
at 75%, the second-highest priority (after education, at
78%).16
The last line of defence for private insurance is that, because it is
"private", it is somehow superior to a "public" system -- a belief,
known as "private sector primacy", which is grounded more in ideology
than in economic rationality. The case does not rest on any economic
analysis of whether a function is more efficiently carried out in the
private or public sector; rather, it is a matter of faith that, if at all
possible, it is always preferable for a function to be in the private
sector. This argument has merit where private provision is
accompanied by the discipline of price signals. But insurance,
private or public, acts to suppress price signals, except for those of
the premiums. At the point of use, there is no difference between the
perception "Medicare will pay" and "private health insurance will
pay". Insurers know this phenomenon by the quaint term "moral
hazard". It applies whenever there is third-party funding.
|
The real debate that we have to have | |
If we dwell too long on the issues of private versus public insurance,
we overlook more basic issues in health financing. We need now to
address wider issues; the longer we defer this debate the harder it
will be, as even uninformed views tend to become entrenched in a state
of serious muddlement. This is especially so in a country with a large
first- and second-generation migrant population, who have come from
countries with a variety of contracts between citizen and
government, from cradle-to-grave welfare through to a culture of
laissez faire.
We offer three issues for this debate.
- First, let us clarify the government's role in healthcare; is it
charity or is it something we share? On that point we tend to the latter
view. Even if we are generally inegalitarian, accepting the slings
and arrows of life as a matter of private fortune, we may have a
different attitude to healthcare. We may know our inheritances of
material wealth and of physical and intellectual talent, but we do not
know what lies around the corner when it comes to health. In the
terminology of the Harvard philosopher John Rawls, when it comes to
our healthcare needs we are in an "original position", and are more
likely to choose to share our lot with others to the extent that we
can.17
- The second issue relates to the boundary between third-party
funding and the market. The debate should not be between private and
public insurance, but between insurance and the market.
- The final issue, after the first two have been settled, is how to
rationalise the complex set of programs in healthcare. To those in the
healthcare professions or who study healthcare from an academic
perspective, it is complex. To the consumer it is
bewilderingly unintelligible. Some programs have copayments, some
do not. Simple procedures like ambulatory care usually require
visits to several establishments, with different payment systems.
Why, for example, is pharmacy separated from general practice? Why
does a public hospital stay attract no copayment, while much less
expensive procedures attract large patient contributions? Why is
medical care separated from nursing care in private hospitals and
nursing homes? Why does one have to wait days for test results which are
generated instantly with new technology?
Program divisions reflect ancient demarcations between crafts, and
the complexities of Federal-State relations. Advances in medical
technology have not been matched in structures and organisations
providing healthcare. If Shaw had lived to 150, he would have found
them surprisingly familiar. Will they be the same on his 175th
birthday?
|
Acknowledgements | |
We extend our thanks to Professor John Deeble for helpful comments on
drafts of this paper and to Amanda Dominello for assistance with
editing.
|
|
| Footnotes |
* Aneurin Bevan, Minister for Health in the Labour Party (United Kingdom), 1945-1951.
Clement Attlee, Leader of the Labour Party (United Kingdom), 1935-1955.
Bob Hawke, Labor Prime Minister, 1983-1991.
|
|
|
References |
- Organisation for Economic Co-operation and Development.
Financing and delivering health care. Paris: OECD; 1987.
-
McAuley I. Private health Insurance. Redefining the issues.
Australian Rationalist 1988; 1 Spring: 47.
-
Lindblom C. The science of muddling through. Public Admin Rev
1959; 19: 79-88.
-
Industry Commission. Private health insurance. Canberra:
Industry Commission, 1997.
-
Australian Bureau of Statistics. Population projections.
Canberra: ABS, April 2000. (Catalogue No. 3220.0.)
-
Organisation for Economic Co-operation and Development. OECD
health data 99 [on CD-ROM]. Paris: OECD, 1999.
-
Stapleton S. New technology, smarter patients augur vast change.
American Medical News 2000; March 13: 33.
-
Callahan D. False hopes. New York: Simon and Schuster, 1997.
-
Marmot M. Social determinants of health: from observation to
policy. Med J Aust 2000; 172: 379-382.
-
Mathers C, Vos T, Stevenson C. The burden of disease and injury in
Australia. Australian Institute of Health and Welfare. Canberra:
AIHW, 1999.
-
Newhouse JP. Keynote address: The costs of medical care and
consumer willingness to pay for new medical technologies: how much
should we be spending on health care? National Health Summit, Nov 15,
Sydney 1991.
-
Clarke RL. Hard times and great expectations. Healthcare
Financial Management 2000; March: 16.
-
Private Health Insurance Administration Council (PHIAC).
Operations of the registered health benefits organisations.
Canberra: PHIAC, 1999: 87.
-
Health Insurance Commission (HIC). Annual report 1998-99.
Canberra: HIC, 1999: 79.
-
Bean C, McAllister I. Short-term influences on voting behaviour
in the 1996 election. In: Bean C, Simms M, Bennett S, Warhurst J,
editors. The politics of retribution -- The 1996 Federal Election.
Sydney: Allen and Unwin, 1997: 198.
-
Peering into 2010 -- a survey of the future of medicine. The
Economist 1994; March 19: 63.
-
Rawls JA. Theory of justice. Cambridge: Harvard University
Press, 1971.
|
Authors' details |
|  |
Stephen Leeder is Dean of the Faculty of Medicine and
Professor of Public Health and Community Medicine at the University
of Sydney. He was foundation professor of Community Medicine at the
University of Newcastle (1977-1985), and Director of the Division of
Public Health and Community Medicine at Westmead Hospital in the
Western Sydney Area Health Service (1985-1997). He was the
foundation chair of the Board of Censors of the Australasian Faculty
of Public Health Medicine 1990-1994, and has served two terms as
National President of the Public Health Association of Australia. He
chaired the Health Advisory Committee of the National Health and
Medical Research Council, 1997-1999.
|
 |
Ian McAuley has worked as an engineer, as a diplomat in the
foreign service, and in the Commonwealth public service. He studied
public administration at Harvard, and since 1987 has been at the
University of Canberra, researching and teaching in public sector
finance.
|
Faculty of Medicine, University of Sydney, Sydney, NSW.
Stephen R Leeder, PhD, FRACP, FFPHM, FAFPHM, Dean, and Professor of
Public Health and Community Medicine.
School of Management and Policy, University of Canberra, Canberra,
ACT.
Ian A McAuley, BE, DipBus, MPA, Lecturer.
Reprints will not be available from the authors. Correspondence:
Professor S R Leeder, Dean, Faculty of Medicine, Edward Ford
Building, University of Sydney, NSW 2006.
steveATmedicine.usyd.edu.au
|
|
|
©MJA 2000
Make a
comment
Readers may print a single copy for personal use. No further
reproduction or distribution of the articles
should proceed without the permission of the publisher. For
permission, contact the
Australasian Medical Publishing Company.
Journalists are welcome to write news stories based on what they read here, but should acknowledge their source as "an article published on the Internet by The Medical Journal of Australia <http://www.mja.com.au>".
<URL: http://www.mja.com.au/>
© 2000 Medical Journal of Australia.
We appreciate
your comments.
|
|
|  |
| Back to text |
| |
|  |
| Back to text |
| |
|  |
| Back to text |
|